Zobrazeno 1 - 10
of 279
pro vyhledávání: '"Paranagama D"'
Autor:
Holtan SG; Univeristy of Minnesota, Minneapolis, MN, USA. sgholtan@umn.edu., Yu J; Incyte Corporation, Wilmington, DE, USA., Paranagama D; Incyte Corporation, Wilmington, DE, USA., Tang J; Asclepius Analytics, New York, NY, USA., Choe HK; The Ohio State University, Columbus, OH, USA., Naim A; Incyte Corporation, Wilmington, DE, USA., Joachim Deeg H; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Galvin J; Incyte Corporation, Wilmington, DE, USA.; University of Illinois Cancer Center, Chicago, IL, USA.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2022 Sep; Vol. 57 (9), pp. 1399-1404. Date of Electronic Publication: 2022 Jun 23.
Autor:
Holtan SG; Univeristy of Minnesota, Minneapolis, MN, USA. sgholtan@umn.edu., Yu J; Incyte Corporation, Wilmington, DE, USA., Choe HK; The Ohio State University, Columbus, OH, USA., Paranagama D; Incyte Corporation, Wilmington, DE, USA., Tang J; Asclepius Analytics, New York, NY, USA., Naim A; Incyte Corporation, Wilmington, DE, USA., Galvin J; Incyte Corporation, Wilmington, DE, USA.; University of Illinois Cancer Center, Chicago, IL, USA., Joachim Deeg H; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2023 Feb; Vol. 58 (2), pp. 237.
Autor:
Yu J; Incyte Corporation, Wilmington, Delaware, USA., Paranagama D; Incyte Corporation, Wilmington, Delaware, USA., Hanna B; Asclepius Analytics LLC, New York City, New York, USA., Tang J; Asclepius Analytics LLC, New York City, New York, USA., Chojecki A; Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Publikováno v:
Acta haematologica [Acta Haematol] 2023; Vol. 146 (1), pp. 26-36. Date of Electronic Publication: 2022 Aug 24.
Autor:
Holtan SG; Univeristy of Minnesota, Minneapolis, MN, USA. sgholtan@umn.edu., Yu J; Incyte Corporation, Wilmington, DE, USA., Choe HK; The Ohio State University, Columbus, OH, USA., Paranagama D; Incyte Corporation, Wilmington, DE, USA., Tang J; Asclepius Analytics, New York, NY, USA., Naim A; Incyte Corporation, Wilmington, DE, USA., Galvin J; Incyte Corporation, Wilmington, DE, USA.; University of Illinois Cancer Center, Chicago, IL, USA., Joachim Deeg H; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2022 Oct; Vol. 57 (10), pp. 1581-1585. Date of Electronic Publication: 2022 Jul 30.
Autor:
Gerds AT; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH. Electronic address: gerdsa@ccf.org., Lyons RM; Texas Oncology and US Oncology Research, San Antonio, TX., Colucci P; Incyte Corporation, Wilmington, DE., Kalafut P; Incyte Corporation, Wilmington, DE., Paranagama D; Incyte Corporation, Wilmington, DE., Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Jul; Vol. 22 (7), pp. e532-e540. Date of Electronic Publication: 2022 Feb 08.
Autor:
Schroeder MA; Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA. markschroeder@wustl.edu., Hari PN; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Blithe A; US Medical Affairs, Incyte Corporation, Wilmington, DE, USA., Paranagama D; US Medical Affairs, Incyte Corporation, Wilmington, DE, USA., Bhatt V; US Medical Affairs, Incyte Corporation, Wilmington, DE, USA., DiPersio JF; Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2022 Jun; Vol. 57 (6), pp. 975-981. Date of Electronic Publication: 2022 Apr 18.
Autor:
Zwicker JI; Beth Israel Deaconess Medical Center, Division of Hematology, Harvard Medical School, Boston, MA. jzwicker@bidmc.harvard.edu., Paranagama D; Incyte Corporation, Wilmington, DE., Lessen DS; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL., Colucci PM; Incyte Corporation, Wilmington, DE., Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC.
Publikováno v:
Haematologica [Haematologica] 2022 May 01; Vol. 107 (5), pp. 1106-1110. Date of Electronic Publication: 2022 May 01.
Autor:
Gerds AT; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA., Yu J; Incyte Corporation, Wilmington, Delaware, USA, jyu@incyte.com., Scherber RM; Incyte Corporation, Wilmington, Delaware, USA., Paranagama D; Incyte Corporation, Wilmington, Delaware, USA., Kish JK; Cardinal Health Specialty Solutions, Dublin, Ohio, USA., Visaria J; HealthCore, Inc., Wilmington, Delaware, USA., Singhal M; HealthCore, Inc., Wilmington, Delaware, USA., Verstovsek S; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pemmaraju N; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Acta haematologica [Acta Haematol] 2022; Vol. 145 (4), pp. 448-453. Date of Electronic Publication: 2022 Jan 10.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Altomare I; Duke University School of Medicine, Durham, NC. Electronic address: ivy.altomare@duke.edu., Parasuraman S; Incyte Corporation, Wilmington, DE., Paranagama D; Incyte Corporation, Wilmington, DE., Kish J; Cardinal Health Specialty Solutions, Dublin, OH., Lord K; Cardinal Health Specialty Solutions, Dublin, OH., Yu J; Incyte Corporation, Wilmington, DE., Colucci P; Incyte Corporation, Wilmington, DE.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2021 Nov; Vol. 21 (11), pp. e915-e921. Date of Electronic Publication: 2021 Jul 04.